EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Two redundant transcription factor binding sites in a single enhancer are essential for mammalian sex determination

Meshi Ridnik, Elisheva Abberbock, Veronica Alipov, Shelly Ziv Lhermann, Shoham Kaufman, Maor Lubman, Francis Poulat, Nitzan Gonen iD

Nucleic Acids Research · 10.06.2024 · 52 (10) · 5514-5528

DOI: 10.1093/nar/gkae178 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 18.03.2024. Verfasst von Meshi Ridnik und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Mina and Everard Goodman Faculty of Life Sciences and the Institute of Nanotechnology and Advanced Materials, Bar-Ilan University, Ramat Gan 5290…. Hauptthemen laut MEDLINE: Enhancer Elements, Genetic, Sex Determination Processes. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Israel Science Foundation, European Union, ANR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Male development in mammals depends on the activity of the two SOX gene: Sry and Sox9, in the embryonic testis. As deletion of Enhancer 13 (Enh13) of the Sox9 gene results in XY male-to-female sex reversal, we explored the critical elements necessary for its function and hence, for testis and male development. Here, we demonstrate that while microdeletions of individual transcription factor binding sites (TFBS) in Enh13 lead to normal testicular development, combined microdeletions of just two SRY/SOX binding motifs can alone fully abolish Enh13 activity leading to XY male-to-female sex reversal. This suggests that for proper male development to occur, these few nucleotides of non-coding DNA must be intact. Interestingly, we show that depending on the nature of these TFBS mutations, dramatically different phenotypic outcomes can occur, providing a molecular explanation for the distinct clinical outcomes observed in patients harboring different variants in the same enhancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Enhancer Elements, GeneticSex Determination ProcessesAnimalsFemaleHumansMaleMiceBinding SitesSequence DeletionSex-Determining Region Y ProteinSOX9 Transcription FactorTestisPhenotype

Substanzen

Sex-Determining Region Y ProteinSOX9 Transcription Factor

Autor:innen und Institutionen

  • The Mina and Everard Goodman Faculty of Life Sciences and the Institute of Nanotechnology and Advanced Materials, Bar-Ilan University, Ramat Gan 5290002, Israel.
  • Group "Development and Pathology of the Gonad". Department of Genetics, Cell Biology and Development, Institute of Human Genetics, CNRS-University of Montpellier UMR9002, Montpellier, France.

ORCID-Profile: Nitzan Gonen

Förderung

  • Israel Science Foundation
  • European Union
  • ANR

Zitieren

APA

Ridnik, M., Abberbock, E., Alipov, V., Lhermann, S. Z., Kaufman, S., Lubman, M., Poulat, F., & Gonen, N. (2024). Two redundant transcription factor binding sites in a single enhancer are essential for mammalian sex determination. Nucleic Acids Research, 52(10), 5514-5528. https://doi.org/10.1093/nar/gkae178

Vancouver

Ridnik M, Abberbock E, Alipov V, Lhermann SZ, Kaufman S, Lubman M, et al. Two redundant transcription factor binding sites in a single enhancer are essential for mammalian sex determination. Nucleic Acids Research. 2024;52(10):5514-5528. doi:10.1093/nar/gkae178

BibTeX
@article{Ridnik2024,
  author = {Ridnik, Meshi and Abberbock, Elisheva and Alipov, Veronica and Lhermann, Shelly Ziv and Kaufman, Shoham and Lubman, Maor and Poulat, Francis and Gonen, Nitzan},
  title = {Two redundant transcription factor binding sites in a single enhancer are essential for mammalian sex determination},
  journal = {Nucleic Acids Research},
  year = {2024},
  volume = {52},
  number = {10},
  pages = {5514--5528},
  doi = {10.1093/nar/gkae178}
}
Kostenlos starten →